These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26946348)

  • 21. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
    Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
    J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1762-9. PubMed ID: 23808759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of FibroScan in liver fibrosis evaluation in patients with chronic hepatitis B virus infection and related influencing factors].
    Xie QX; Xu N; Jiang XP; Zhang YF; Zhang ZH; Li JB; Hu XY; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):659-664. PubMed ID: 27788721
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients.
    Liang LB; Zhu X; Yan LB; Du LY; Liu C; Chen LY; Liao J; Tang H
    Ther Clin Risk Manag; 2015; 11():229-35. PubMed ID: 25709465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
    Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
    BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Manolakopoulos S; Margariti A; Papageorgiou MV; Kranidioti H; Katoglou A; Kontos G; Adamidi S; Kafiri G; Deutsch M; Pectasides D
    J Viral Hepat; 2014 Jul; 21(7):517-24. PubMed ID: 24750382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
    Fung J; Lai CL; Wong DK; Seto WK; Hung I; Yuen MF
    J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
    Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
    Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
    Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognosis and management of inactive HBV carriers.
    Invernizzi F; Viganò M; Grossi G; Lampertico P
    Liver Int; 2016 Jan; 36 Suppl 1():100-4. PubMed ID: 26725905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
    Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
    Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000-20000 IU/ml with ALT 1-2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT.
    Danis N; Salih Akarca U; Turan I; Karasu Z; Ersoz G; Yilmaz F; Nart D; Zeytinoglu A; Selda Erensoy M; Gunsar F
    North Clin Istanb; 2021; 8(6):568-574. PubMed ID: 35284786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.
    Kim SU; Park JY; Kim DY; Ahn SH; Choi EH; Seok JY; Lee JM; Park YN; Chon CY; Han KH
    Hepatol Int; 2010 Aug; 4(4):673-80. PubMed ID: 21286337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
    PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase.
    Alam MM; Mahtab MA; Akbar SM; Kamal M; Rahman S
    Bangladesh Med Res Counc Bull; 2014 Dec; 40(3):92-6. PubMed ID: 26402972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].
    Zhang XY; Qian J; Li P; Hu LH; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):332-336. PubMed ID: 29996199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.